​Dr Max Ortiz Catalan at Chalmers has developed a new theory for the origin of the mysterious condition, ‘phantom limb pain’. Published in the journal Frontiers in Neurology, his hypothesis builds upon his previous work on a revolutionary treatment for the condition, that uses machine learning and augmented reality.​

It’s that time of year again. Store shelves are stocked full of back-to-school items and parents are making decisions about what to buy.

New research reveals the vast incompatibility of current models of economic development with environmental sustainability.

Losing a single night’s sleep may affect the liver’s ability to produce glucose and process insulin, increasing the risk of metabolic diseases such as hepatic steatosis (fatty liver) and type 2 diabetes. The findings of the mouse study are published ahead of print in the American Journal of Physiology—Endocrinology and Metabolism. The research was chosen as an APSselect article for September.

Small, New World monkeys called marmosets can mimic the sleep disturbances, changes in circadian rhythm, and cognitive impairment people with Parkinson’s disease develop, according to a new study by scientists at Texas Biomedical Research Institute.

​It doesn’t matter if it’s rye, oats, or wheat. As long as it is wholegrain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers and the Danish Cancer Society Research Center.

Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared online in Scientific Reports.

Scientists at the Salk Institute found that mice lacking the biological clocks thought to be necessary for a healthy metabolism could still be protected against obesity and metabolic diseases by having their daily access to food restricted to a 10-hour window.

Middle-aged adults are exercising more and living longer, but new research from the University of British Columbia suggests that even the fittest among them are not immune to cardiovascular disease—and they often don’t have any symptoms.

A suppository form of the common antimalarial artesunate has dramatically cut child deaths from severe malaria in a trial in rural Zambia, one of the organisations behind the programme has said.